Concepedia

Andreas Fredenhagen

AF

Statistics

Publications

29

Citations

1.2K

H-Index

20

Active since

1985

Affiliations

Novartis (Switzerland)(Current)

Drug Discovery Laboratory (Norway)

Hamburg University of Technology

Pharmaceutical Biotechnology (Czechia)

Novartis Institutes for BioMedical Research

Andreas Fredenhagen is an author at Novartis (Switzerland) specializing in life sciences, biochemistry, and medicinal chemistry.

Publications per year

1985–2018

29

Publications

29

Andrimid, a new peptide antibiotic produced by an intracellular bacterial symbiont isolated from a brown planthopper

Andreas Fredenhagen, Susan Y. Tamura, Peter T.M. Kenny et al. · Journal of the American Chemical Society · 1987 · 167 citations

, , +9

Mode of action of the lanthionine-containing peptide antibiotics duramycin, duramycin B and C, and cinnamycin as indirect inhibitors of phospholipase A2

F. Märki, Elvira Hänni, Andreas Fredenhagen et al. · Biochemical Pharmacology · 1991 · 141 citations

, , +14

Duramycins B and C, two new lanthionine containing antibiotics as inhibitors of phospholipase A2. Structural revision of duramycin and cinnamycin.

Andreas Fredenhagen, Gabriele Fendrich, F. Märki et al. · The Journal of Antibiotics · 1990 · 103 citations · Full text

, , +9

Solution structures of the lantibiotics duramycin B and C

Norbert Zimmermann, Stefan M.V. Freund, Andreas Fredenhagen et al. · European Journal of Biochemistry · 1993 · 83 citations

, , +13

An MS/MS Library on an Ion-Trap Instrument for Efficient Dereplication of Natural Products. Different Fragmentation Patterns for [M + H]<sup>+</sup> and [M + Na]<sup>+</sup> Ions

Andreas Fredenhagen, Caroline Derrien, Ernst Gassmann · Journal of Natural Products · 2005 · 68 citations

, , +15

1–5 of 29